Janssen is a leading pharmaceutical company dedicated to addressing unmet medical needs in rare diseases and orphan drug development. With a strong focus on research and innovation, Janssen is committed to improving the lives of patients with rare diseases through the development of novel therapies and treatments. Their participation at World Orphan Drug Congress USA 2026 demonstrates their dedication to advancing the field of orphan drug development and rare disease management. Janssen's expertise, resources, and commitment to patient care make them a key player in the orphan drug industry.